Infection prevention & Control Market

Date: 2016-05

Infection prevention and Control (IPC) is a rapidly growing field in the healthcare industry. The proper usage of the IPC products all across the globe has the potential to revolutionize the complete healthcare industry, making it disease free. The market opportunity for IPC is promising, yet conflicting financial Incentives has created uncertainty on how stakeholders can capitalize. The market for Infection prevention is estimated to increase with a CAGR of 5.3% during the forecast period 2015-2020. Infection prevention and control market is experiencing significant growth with the increase in awareness among the people, elderly & aging population, and number of surgeries and proper donning and doffing of Hospital Housekeeper which prevents in the spread of the contagious waste.

Infection prevention and control is the major and significant step in the development and maintenance of products in the Medical Devices, Pharmaceuticals, and food & beverage industries. The adoption of various means of personal protective equipment, disinfection, sterilization and in-house sterilization procedures by hospitals and end users industries has revolutionized the healthcare industry. Sterilization and disinfection protect different products and materials from being contaminated by microbes. The disinfection and sterilization market is going to expand with a CAGR of 6.2% during the period under study. The integration of technologies into traditional healthcare systems is one of the most influencing trends that will drive the growth of this market. The technological advancements will facilitate the availability and implementation of cost-effective technologies across a range of healthcare facilities. The introduction of technically enhanced instruments likes portable autoclaves, In-House & ethylene oxide (EtO) advanced sterilization and so on has resulted in the drastic swing from the previous used equipment’s such as steam sterilizer.

The IPC market by anti-microbial drugs in North America in 2014 was valued at $XX billion and is projected to grow at a CAGR of 4.5% during the forecast period. The North American region has been concentrating on relatively easy commercial drugs which were driven by the increase in chronic diseases. This has led to the development of vaccines, since these are specific for a particular infection. The cost of the vaccines varies as per the infected microbes. Thus, followed by anti-bacterial drugs, vaccines show the highest growth rate of 4.8% towards the increasing demand of anti-microbial drugs, where most patients would be managed with a short course of therapy in comparison to the generic antibiotics. According to the World Health Organization, 30.85% of the globally registered hospitals are in the Americas. Moreover, the rapidly aging population in the U.S., Canada and Mexico will drive the need for efficient anti-microbial drugs in hospitals and senior care centres in this region.

The global infection prevention and control market is segmented into bacterial, fungal and viral infections based on the types of microbial infections. In 2014, bacterial infections dominated the market with 44% of the global market share in infection prevention and control market, followed by viral infections, which occupied 39%.

Contact With Us
Join templatemonster at google+
Customized Research
Request Sample